ViveSpoon participated in the Australian immersion programme of JETRO’s J-StarX Medtech course, held in Sydney and Melbourne from 10 to 13 March 2026.
JETRO reported that the six participating ventures visited universities, research institutions, healthcare organisations, and specialists in intellectual property and regulation. The programme included pitches, individual mentoring, and discussions. For ViveSpoon, it provided an opportunity to examine commercialisation, regulatory, clinical-validation, and intellectual-property considerations in Australia.
Participation in the programme does not indicate that a research collaboration, contract, investment, or regulatory agreement was concluded. We will continue assessing possible partnerships in the context of each jurisdiction’s healthcare and regulatory environment.